Posted by Michael Wonder on 27 Jul 2020
CADTH posts final recommendation for Aimovig
26 July 2020 - Final recommendation informed by input from Migraine Canada and Migraine Quebec.
The CADTH Canadian Drug Expert Committee has recommended that erenumab be reimbursed for the prevention of chronic migraine in adults, if certain conditions are met, including a reduction in price.
